申请人:Bradley Marcus Daniel
公开号:US20080090822A1
公开(公告)日:2008-04-17
The invention provides a compound of formula (I) or a salt or solvate thereof: wherein R
1
, n, X, Y and Z are as defined in the specification, and uses of such compounds. The compounds inhibit GlyT1 transporters and are useful in the treatment of certain neurological and neuropsychiatric disorders, including schizophrenia.
该发明提供式(I)的化合物或其盐或溶剂化物:其中R1,n,X,Y和Z如规范中所定义,并提供了这些化合物的用途。这些化合物抑制GlyT1转运体,在治疗某些神经系统和神经精神障碍,包括精神分裂症方面具有用途。